The Dr. Tyna Show

Obesity Isn’t A Willpower Problem: The Role Of GLP-1s | Dr. Spencer Nadolsky

May 15, 2025
Join Dr. Spencer Nadolsky, an obesity specialist and lipidologist, as he uncovers the truth about GLP-1 medications and their impact on metabolic health. He explains obesity as a chronic disease and discusses the real benefits of GLP-1s beyond just weight loss. Dr. Nadolsky addresses misconceptions around dosing and the potential side effects, emphasizing personalized care. He highlights the importance of strength training and nutrition in maintaining muscle mass while tackling industry biases and the complexities of telemedicine in obesity treatment.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Dose Reduction Revives Motivation

  • A woman on a high dose of terzepatide plateaued and felt unmotivated to workout or lose weight.
  • Reducing her dose revived her motivation and helped her break through the plateau to lose more weight.
INSIGHT

Obesity as Chronic Disease

  • Obesity is a chronic disease driven by brain and genetic changes beyond simple willpower.
  • Appetite dysregulation is a key pathological driver, making obesity treatment complex.
INSIGHT

PBMs Inflate US Drug Prices

  • Pharmaceutical pricing and pharmacy benefit managers cause inflated GLP-1 medication costs in the US.
  • This limits access despite the drugs being affordable in other countries.
Get the Snipd Podcast app to discover more snips from this episode
Get the app